Intuitive Surgical Inc

US

ISRG

Health Care

368.93 ₽

Current price

Hold
368.93 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    165 / 663

  • Position in country

    3280 / 14179

  • Return on Assets, %

    12.9

    -11.9

  • Net income margin, %

    31.6

    -12.5

  • EBITDA margin, %

    30.4

    -2.5

  • Debt to Equity, %

    0

    15

  • Intangible assets and goodwill, %

    2.5

    3.9

  • Revenue CAGR 3Y, %

    17.7

    12.6

  • Total Equity change 1Y, %

    20.5

    0

  • Revenue Y, % chg

    14.4

    4.6

  • P/E

    76.5

    28.3

  • P/BV

    10.1

    1.7

  • P/S

    19.1

    3.7

  • EV/S

    18.4

    3.2

  • EV/EBITDA

    58.6

    -0.2

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    10.4

    66.5

  • Forward P/E

    58.7

    19.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0

    17.3

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Resmed Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    136391.8

  • Ticker

    ISRG.O

  • ISIN

    US46120E6023

  • IPO date

    2000-06-13

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-01-31

  • Date fact. publication of reports

    2023-12-31

Company Description

Intuitive Surgical, Inc. develops, manufactures and markets the da Vinci surgical system and Ion endoluminal system. The Company's da Vinci products are offered in categories, including da Vinci Surgical Systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems (Firefly) and da Vinci Endoscopes. It also provides a comprehensive suite of services, training, and education programs. It manufactures a set of instruments, which incorporates EndoWrist technology with wristed joints for natural dexterity and tips customized for various surgical procedures. Its Ion endoluminal system is a robotic-assisted, catheter-based platform designed to navigate through very small lung airways to reach peripheral nodules for biopsies. The da Vinci Surgical System enables surgeons to operate while seated at an ergonomic console viewing a three-dimensional, high definition (3DHD) image of the surgical field.